🔗 Visit the ClinicalTrials.gov page for NCT00006019
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Oxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy. | J Cell Mol Med | 2009 | 1.03 |
| 2 | The potential of panobinostat as a treatment option in patients with relapsed and refractory multiple myeloma. | Ther Adv Hematol | 2014 | 0.88 |
| 3 | Epigenetic modulators as therapeutic targets in prostate cancer. | Clin Epigenetics | 2016 | 0.76 |